NO20043580D0 - Quinazolinonderivater og deres bruk som CB agonister - Google Patents

Quinazolinonderivater og deres bruk som CB agonister

Info

Publication number: NO20043580D0
Authority: NO; Norway
Prior art keywords: agonists; quinazolinone derivatives; quinazolinone; derivatives
Prior art date: 2002-02-06

Application number

NO20043580A

Other languages

English (en)

Other versions

NO20043580L (no

NO328305B1 (no

Inventor

Christopher Thomas Brain

Edward Karol Dziadulewicz

Terance William Hart

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-02-06

Filing date

2004-08-27

Publication date

2004-08-27

2002-02-06 Priority claimed from GB0202755A external-priority patent/GB0202755D0/en

2002-06-10 Priority claimed from GB0213285A external-priority patent/GB0213285D0/en

2002-09-16 Priority claimed from GB0221460A external-priority patent/GB0221460D0/en

2002-09-16 Priority claimed from GB0221459A external-priority patent/GB0221459D0/en

2004-08-27 Application filed by Novartis Ag filed Critical Novartis Ag

2004-08-27 Publication of NO20043580D0 publication Critical patent/NO20043580D0/no

2004-09-21 Publication of NO20043580L publication Critical patent/NO20043580L/no

2010-01-25 Publication of NO328305B1 publication Critical patent/NO328305B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Pulmonology (AREA)
Ophthalmology & Optometry (AREA)
Anesthesiology (AREA)
Psychology (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Rheumatology (AREA)
Otolaryngology (AREA)
Pain & Pain Management (AREA)
Urology & Nephrology (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20043580A 2002-02-06 2004-08-27 Kinazolinonderivater, fremgangsmate for fremstilling og en farmasoytisk sammensetning omfattende disse NO328305B1 (no)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
GB0202755A GB0202755D0 (en)	2002-02-06	2002-02-06	Organic compounds
GB0213285A GB0213285D0 (en)	2002-06-10	2002-06-10	Organic compound
GB0221460A GB0221460D0 (en)	2002-09-16	2002-09-16	Organic compound
GB0221459A GB0221459D0 (en)	2002-09-16	2002-09-16	Organic compound
PCT/EP2003/001140 WO2003066603A1 (en)	2002-02-06	2003-02-05	Quinazolinone derivatives and their use as cb agonists

Publications (3)

Publication Number	Publication Date
NO20043580D0 true NO20043580D0 (no)	2004-08-27
NO20043580L NO20043580L (no)	2004-09-21
NO328305B1 NO328305B1 (no)	2010-01-25

Family

ID=27739227

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20043580A NO328305B1 (no)	2002-02-06	2004-08-27	Kinazolinonderivater, fremgangsmate for fremstilling og en farmasoytisk sammensetning omfattende disse

Country Status (21)

Country	Link
US (2)	US20050085493A1 (no)
EP (2)	EP1472234B1 (no)
JP (2)	JP4428479B2 (no)
KR (1)	KR100954626B1 (no)
CN (1)	CN100579968C (no)
AR (1)	AR038483A1 (no)
AT (1)	ATE551329T1 (no)
AU (1)	AU2003210212A1 (no)
BR (1)	BR0307461A (no)
CA (1)	CA2471974C (no)
CO (1)	CO5601021A2 (no)
EC (1)	ECSP045219A (no)
ES (1)	ES2384967T3 (no)
MX (1)	MXPA04007641A (no)
MY (1)	MY143958A (no)
NO (1)	NO328305B1 (no)
NZ (1)	NZ571615A (no)
PE (1)	PE20030867A1 (no)
PL (1)	PL370657A1 (no)
TW (1)	TW200306839A (no)
WO (1)	WO2003066603A1 (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BR0009083B1 (pt)	1999-03-17	2011-11-01		derivado de amida compreendendo um núcleo de quinazolinona, processo para a preparação de um derivado de amida, composição farmacêutica, e, uso de um derivado de amida.
TW200306839A (en)	2002-02-06	2003-12-01	Novartis Ag	Quinazolinone derivatives and their use as CB agonists
GB0324790D0 (en)	2003-10-24	2003-11-26	Astrazeneca Ab	Amide derivatives
US7728141B2 (en)	2003-11-04	2010-06-01	Merck Sharp & Dohme Corp.	Substituted naphthyridinone derivatives
SE0303491D0 (sv) *	2003-12-19	2003-12-19	Astrazeneca Ab	New use VI
CN100506802C (zh) *	2004-06-04	2009-07-01	中国科学院上海药物研究所	一类甲酰肽样受体-1调节剂、其制备方法和用途
GB0413618D0 (en) *	2004-06-17	2004-07-21	Novartis Ag	Organic compounds
EP1904068A1 (en) *	2005-07-11	2008-04-02	N.V. Organon	Synergistic combination for the treatment of pain (cannabioid receptor agonist and opiod receptor agonist)
GB0525068D0 (en)	2005-12-08	2006-01-18	Novartis Ag	Organic compounds
US20090209536A1 (en) *	2007-06-17	2009-08-20	Kalypsys, Inc.	Aminoquinazoline cannabinoid receptor modulators for treatment of disease
US8349852B2 (en)	2009-01-13	2013-01-08	Novartis Ag	Quinazolinone derivatives useful as vanilloid antagonists
FR2944013B1 (fr) *	2009-04-07	2011-07-15	Sanofi Aventis	Derives de 1-alkyl-cinnolin-4(1h)-one substitues,leur preparation et leur application en therapeutique.
CN102762572A (zh)	2010-02-01	2012-10-31	诺瓦提斯公司	作为CRF-1受体拮抗剂的吡唑并[5,1b]*唑衍生物
WO2011092293A2 (en)	2010-02-01	2011-08-04	Novartis Ag	Cyclohexyl amide derivatives as crf receptor antagonists
CN102753527B (zh)	2010-02-02	2014-12-24	诺华股份有限公司	用作crf受体拮抗剂的环己基酰胺衍生物
UY34094A (es)	2011-05-27	2013-01-03	Novartis Ag	Derivados de la piperidina 3-espirocíclica como agonistas de receptores de la ghrelina
EA201491990A1 (ru)	2012-05-03	2015-02-27	Новартис Аг	L-малатная соль 2,7-диазаспиро[4.5]дец-7-иловых производных и их кристаллические формы в качестве агонистов грелиновых рецепторов
UY35675A (es)	2013-07-24	2015-02-27	Novartis Ag	Derivados sustituidos de quinazolin-4-ona
CN106146414A (zh) *	2016-07-07	2016-11-23	浙江大学	喹唑啉二酮类衍生物及其制备方法和用途
CN106831502A (zh) *	2017-03-13	2017-06-13	苏州市泽宸贸易有限公司	邻硝基苯磺酰氯、其合成方法及应用
CN109796360B (zh) *	2019-01-30	2022-03-18	上海阿拉丁生化科技股份有限公司	一种3-氨基-2-萘甲酸类化合物的制备工艺

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR6200M (no)	1967-04-18	1968-07-22
DE1803210A1 (de)	1968-10-16	1970-05-14	Troponwerke Dinklage & Co	2-Methyl-3-(3-[4-phenylpiperazinyl-(1)]-2-hydroxypropyl)-chinazolinon-(4) und Verfahren zu seiner Herstellung
JPS5657768A (en) *	1979-10-18	1981-05-20	Masayuki Ishikawa	Novel 4-quinazolone derivative substituted by aromatic residue at 3-position
NZ192392A (en) *	1978-12-19	1983-02-15	M Ishikawa	3-(substituted (phenyl or pyridyl)) -3,4-dihydroquinazolin-4-ones
AU543928B2 (en) *	1981-01-16	1985-05-09	Masayuki Ishikawa	4(311)-quinazolinone derivatives
JPS57118570A (en) *	1981-01-16	1982-07-23	Masayuki Ishikawa	Novel 3-phenyl-4-quinazolone derivative
EP0639986A1 (en) *	1992-05-13	1995-03-01	Alcon Laboratories, Inc.	Topical ophthalmic compositions comprising a combination of calcium antagonists with known antiglaucoma agents
AU1618697A (en)	1996-02-06	1997-08-28	Japan Tobacco Inc.	Novel compounds and pharmaceutical use thereof
TW200306839A (en)	2002-02-06	2003-12-01	Novartis Ag	Quinazolinone derivatives and their use as CB agonists
SE0303491D0 (sv)	2003-12-19	2003-12-19	Astrazeneca Ab	New use VI
GB0413618D0 (en) *	2004-06-17	2004-07-21	Novartis Ag	Organic compounds

2003
- 2003-01-30 TW TW092102105A patent/TW200306839A/zh unknown
- 2003-02-04 AR ARP030100347A patent/AR038483A1/es unknown
- 2003-02-04 PE PE2003000129A patent/PE20030867A1/es not_active Application Discontinuation
- 2003-02-05 CN CN03803448A patent/CN100579968C/zh not_active Expired - Fee Related
- 2003-02-05 EP EP03737316A patent/EP1472234B1/en not_active Expired - Lifetime
- 2003-02-05 AT AT03737316T patent/ATE551329T1/de active
- 2003-02-05 WO PCT/EP2003/001140 patent/WO2003066603A1/en not_active Ceased
- 2003-02-05 MX MXPA04007641A patent/MXPA04007641A/es unknown
- 2003-02-05 ES ES03737316T patent/ES2384967T3/es not_active Expired - Lifetime
- 2003-02-05 AU AU2003210212A patent/AU2003210212A1/en not_active Abandoned
- 2003-02-05 KR KR1020047012147A patent/KR100954626B1/ko not_active Expired - Fee Related
- 2003-02-05 JP JP2003565977A patent/JP4428479B2/ja not_active Expired - Fee Related
- 2003-02-05 NZ NZ571615A patent/NZ571615A/en not_active IP Right Cessation
- 2003-02-05 CA CA2471974A patent/CA2471974C/en not_active Expired - Fee Related
- 2003-02-05 US US10/503,779 patent/US20050085493A1/en not_active Abandoned
- 2003-02-05 PL PL03370657A patent/PL370657A1/xx unknown
- 2003-02-05 BR BR0307461-7A patent/BR0307461A/pt active Search and Examination
- 2003-02-05 EP EP10175740A patent/EP2319839A1/en not_active Withdrawn
- 2003-02-05 MY MYPI20030387A patent/MY143958A/en unknown
2004
- 2004-08-04 EC EC2004005219A patent/ECSP045219A/es unknown
- 2004-08-25 CO CO04083224A patent/CO5601021A2/es not_active Application Discontinuation
- 2004-08-27 NO NO20043580A patent/NO328305B1/no not_active IP Right Cessation
2007
- 2007-06-26 US US11/823,315 patent/US8552015B2/en not_active Expired - Fee Related
2009
- 2009-01-22 JP JP2009012064A patent/JP2009149658A/ja active Pending

Also Published As

Publication number	Publication date
EP1472234A1 (en)	2004-11-03
MXPA04007641A (es)	2004-11-10
TW200306839A (en)	2003-12-01
CN1628104A (zh)	2005-06-15
HK1079518A1 (zh)	2006-04-07
CA2471974C (en)	2011-11-22
US20050085493A1 (en)	2005-04-21
NZ571615A (en)	2010-01-29
US8552015B2 (en)	2013-10-08
NO20043580L (no)	2004-09-21
ECSP045219A (es)	2004-09-28
AR038483A1 (es)	2005-01-19
KR20040083501A (ko)	2004-10-02
JP2009149658A (ja)	2009-07-09
KR100954626B1 (ko)	2010-04-27
ES2384967T3 (es)	2012-07-16
EP2319839A1 (en)	2011-05-11
MY143958A (en)	2011-07-29
US20070265285A1 (en)	2007-11-15
ATE551329T1 (de)	2012-04-15
AU2003210212A1 (en)	2003-09-02
JP2005522439A (ja)	2005-07-28
BR0307461A (pt)	2004-11-09
CN100579968C (zh)	2010-01-13
EP1472234B1 (en)	2012-03-28
NO328305B1 (no)	2010-01-25
CO5601021A2 (es)	2006-01-31
CA2471974A1 (en)	2003-08-14
PE20030867A1 (es)	2003-12-04
JP4428479B2 (ja)	2010-03-10
PL370657A1 (en)	2005-05-30
WO2003066603A1 (en)	2003-08-14

Publication	Publication Date	Title
NO20026010L (no)	2002-12-13	Substituerte quinazolinderivater og deres anvendelse som inhibitorer
NO20043580D0 (no)	2004-08-27	Quinazolinonderivater og deres bruk som CB agonister
DK1480962T3 (da)	2011-12-05	5-Phenylthiazol-derivater og deres anvendelse som P1-3-kinaseinhibitorer
DK1478629T3 (da)	2007-01-29	N-aryl-2-oxazolidinon-5-carboxamider og deres derivater og deres anvendelse som antibakterielle midler
NO20053356D0 (no)	2005-07-11	Aminindazolderivater og anvendelse derav som kinaseinhibitorer.
DK1956004T3 (da)	2012-08-06	Quinolinderivater og deres anvendelse som 5-HT6-ligander
DK1480955T3 (da)	2007-10-29	O-cyclopropyl-carboxanilider og deres anvendelse som fungicider
DK1527050T3 (da)	2010-07-19	Quinolin-derivater og deres anvendelse som mycobakterielle inhibitorer
DK1578755T3 (da)	2007-11-12	Phosphonooxyguinalinderivater og deres farmaceutiske anvendelse
IS6934A (is)	2003-08-29	Nýjar spírótrísýklískar afleiður og notkun þeirrasem fosfódíesterasa-7-hindrar
DK1499311T3 (da)	2010-03-08	Substituerede benzaboler og anvendelse deraf som RAF-kinaseinhibitorer
DK1558615T3 (da)	2007-12-03	Purin-forbindelser og deres anvendelse som cannabinoid receptor ligander
NO20044137L (no)	2004-11-25	Aminoindazolderivater, deres fremstilling og anvendelse samt mellomprodukter
DK1368349T3 (da)	2007-05-21	Xanthinderivater, deres fremstilling og deres anvendelse som lægemidler
DK1581532T3 (da)	2010-08-16	Pyrazolo-3,4-B pyridinforbindelser og deres anvendelse som phosphodiesterase inhibitorer
DK1761529T3 (da)	2008-03-25	Pyrrolopyridinderivater og deres anvendelse som CRTh2-antagonister
DK1539712T3 (da)	2008-03-17	Pyrimidinderivater og deres anvendelse som CB2-modulatorer
DK1133477T3 (da)	2004-06-21	Substituerede benzimidazoler og deres anvendelse som parpinhibitorer
DK1455785T3 (da)	2009-06-08	Substituerede 2-thio-3,5-dicyano-4-phenyl-6-aminopyridiner og deres anvendelse
NO20031952L (no)	2003-07-22	3-aroylinderivater og deres anvendelse som CB2 reseptoragonister
NO20042719L (no)	2004-06-28	Substituerte 2-amino-cykloalkankarboksamider og deres anvendelse som protease-inhibitorer
NO20050665L (no)	2005-04-18	Pyrrolidonderivater som MAOE inhibitoere
DK1581518T3 (da)	2011-06-06	Substituerede 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazin-derivater og deres anvendelse som neurokinin antagonister
NO20043349L (no)	2004-10-05	Kumarinderivater, fremgangsmate for deres framstilling og anvendelse derav
DK1387838T3 (da)	2006-08-14	Cyanoanthranylamid-derivater og deres anvendelse som lægemidler

Legal Events

Date	Code	Title	Description
2012-10-01	MM1K	Lapsed by not paying the annual fees